Literature DB >> 9394711

Fatty acids and colon cancer in experimental models.

D M Klurfeld1, A W Bull.   

Abstract

Experimental models have several advantages in the study of colon cancer. They can be used to tightly control diet, examine putative intermediate markers, test hypotheses about mechanisms of carcinogenesis, and quantify development of tumors in a short time. Dietary issues that have been studied in animal models but are unresolved include the concept of the effects of total fat compared with energy intake, composition of the basal diet, linoleic acid requirements, and interactions of fat with other nutrients. Intermediate markers that have been probed in animal or in vitro studies include cytokinetics, aberrant crypt foci, eicosanoids and hydroxyoctadecadienoic acids, ornithine decarboxylase, tyrosine kinase, protein kinase C, and gene expression. Colon cancer is studied in animals primarily with use of chemicals that are relatively specific inducers of these tumors, but transplantable models and transgenic animals are also used. Total dietary fat is generally thought to affect colon tumorigenesis, but there does not appear to be any specific fatty acid that promotes the development of colon cancer. Several studies indicate that n-3 fatty acids from marine sources alter a variety of biological intermediates and inhibit colonic tumorigenesis; this is probably mediated via the eicosanoid pathway. Although there are undoubtedly multiple cellular changes elicited by certain fatty acids, our current knowledge of this area suggests that specific fatty acid metabolites or their targets are the likely mediators in this sequence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9394711     DOI: 10.1093/ajcn/66.6.1530S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

1.  Colorectal cancer cell growth inhibition by linoleic acid is related to fatty acid composition changes.

Authors:  Xiao-feng Lu; Guo-qing He; Hai-ning Yu; Qi Ma; Sheng-rong Shen; Undurti N Das
Journal:  J Zhejiang Univ Sci B       Date:  2010-12       Impact factor: 3.066

2.  A prospective study of dietary polyunsaturated fatty acids and colorectal cancer risk in Chinese women.

Authors:  Harvey J Murff; Xiao-Ou Shu; Honglan Li; Qi Dai; Asha Kallianpur; Gong Yang; Hui Cai; Wanqing Wen; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

Review 3.  Are the olive oil and other dietary lipids related to cancer? Experimental evidence.

Authors:  E Escrich; M Solanas; R Moral; I Costa; L Grau
Journal:  Clin Transl Oncol       Date:  2006-12       Impact factor: 3.405

4.  A prospective study of dietary polyunsaturated fatty acids intake and lung cancer risk.

Authors:  Hung N Luu; Hui Cai; Harvey J Murff; Yong-Bing Xiang; Qiuyin Cai; Honglan Li; Jing Gao; Gong Yang; Qing Lan; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu
Journal:  Int J Cancer       Date:  2018-08-07       Impact factor: 7.396

5.  Linoleic acid suppresses colorectal cancer cell growth by inducing oxidant stress and mitochondrial dysfunction.

Authors:  Xiaofeng Lu; Haining Yu; Qi Ma; Shengrong Shen; Undurti N Das
Journal:  Lipids Health Dis       Date:  2010-09-24       Impact factor: 3.876

6.  Age- and diet-related increase in transepithelial colon permeability of Fischer 344 rats.

Authors:  J M Mullin; M C Valenzano; J J Verrecchio; R Kothari
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

7.  Serum n-3 fatty acids, fish consumption and cancer mortality in six Japanese populations in Japan and Brazil.

Authors:  M Kobayashi; S Sasaki; G S Hamada; S Tsugane
Journal:  Jpn J Cancer Res       Date:  1999-09

8.  Effects of polyunsaturated fatty acids on the growth of gastric cancer cells in vitro.

Authors:  Jinfeng Dai; Junhui Shen; Wensheng Pan; Shengrong Shen; Undurti N Das
Journal:  Lipids Health Dis       Date:  2013-05-10       Impact factor: 3.876

Review 9.  Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer.

Authors:  Xian-Zhong Ding; Rene Hennig; Thomas E Adrian
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.